Publications by authors named "Shinichiro Sano"

Article Synopsis
  • * The presence of anti-GAD antibodies is linked to type 1 diabetes and various neurological disorders collectively referred to as GAD antibody-spectrum disorders (GAD-SD).
  • * A case study of a 17-year-old male who developed GAD-SD and type 1 diabetes after a stem cell transplant is presented, showing symptoms like memory issues and abnormal brain scans, leading to treatment with steroids and insulin.
View Article and Find Full Text PDF

Context: Defects in MKRN3, DLK1, KISS1, and KISS1R and some disorders, such as Temple syndrome (TS14), cause central precocious puberty (CPP). Recently, pathogenic variants (PVs) in MECP2 have been reported to be associated with CPP.

Objective: We aimed to clarify the contribution of (epi)genetic abnormalities to CPP and clinical and hormonal features in each etiology.

View Article and Find Full Text PDF

Aim: The present study assessed low-density lipoprotein cholesterol (LDL-C) levels in school-aged children from the Ogasa District of Shizuoka Prefecture and evaluated the utility of non-invasive vascular tests, namely flow-mediated dilation (FMD) and intima-media thickness (IMT), in pediatric patients with familial hypercholesterolemia (FH).

Method: We analyzed the lipid test results of 8,568 students screened for prevention of lifestyle-related diseases and 78 children under 15 years old with cholesterol levels exceeding 220 mg/dL who visited Chutoen General Medical Center. We examined the LDL-C distribution from school-age screenings and conducted FMD and IMT assessments on those meeting the 2022 Pediatric FH Guidelines criteria.

View Article and Find Full Text PDF

We encountered a Chinese girl with pseudohypoparathyroidism type 1A (PHP1A) and her mother with pseudopseudohypoparathyroidism (PPHP). Sequencing analysis of -Gsα revealed a heterozygous c.212+2T>C variant (NM_000516.

View Article and Find Full Text PDF
Article Synopsis
  • This study focused on Pseudohypoparathyroidism type 1B (PHP1B) and its various causes linked to methylation defects on the GNAS locus, aiming to clarify clinical characteristics within different patient groups.
  • Researchers analyzed 84 patients, categorizing them into five groups based on their methylation patterns and inheritance types, looking at symptoms and ages at diagnosis.
  • Results showed that the sporadic PHP1B group had younger patients and distinct symptoms compared to others, and while neurodevelopmental disorders were noted, no clear links were found between methylation ratios and hormone levels.
View Article and Find Full Text PDF

Although 17β-hydroxysteroid dehydrogenase type 3 (HSD17B3) deficiency is diagnosed when a testosterone/androstenedione (T/A-dione) ratio after human chorionic gonadotropin (hCG) stimulation is below 0.8, this cut-off value is primarily based on hormonal data measured by conventional immunoassay (IA) in patients with feminized or ambiguous genitalia. We examined two 46,XY Japanese patients with undermasculinized genitalia including hypospadias (patient 1 and patient 2).

View Article and Find Full Text PDF
Article Synopsis
  • A study indicated that assisted reproductive technology (ART) might be a risk factor for epimutation-mediated imprinting disorders in mothers aged 30 and older, but its effect on uniparental disomy-mediated imprinting disorders (UPD-IDs) remains uncertain.
  • Researchers assessed 130 patients with aneuploid UPD-IDs and compared ART-conceived birth rates and maternal ages with those in the general population and patients with epi-IDs, finding no significant differences, although UPD-IDs patients tended to be older.
  • The analysis revealed that nearly all ART-conceived births occurred in patients with aneuploid oocyte-derived UPD-IDs (oUPD-IDs), who also had significantly older
View Article and Find Full Text PDF

Recent studies have indicated that heterozygous loss-of-function variants in fibroblast growth factor receptor 1 () are involved in the development of congenital hypogonadotropic hypogonadism and combined pituitary hormone deficiency (CPHD). We encountered a Japanese boy with short stature and pubertal failure. Endocrine studies showed GH, TSH, and LH/FSH deficiencies, and brain magnetic resonance imaging delineated hypoplastic anterior pituitary and ectopic posterior pituitary.

View Article and Find Full Text PDF

Loss of methylation (LOM) at GNAS-A/B:TSS-differentially methylated regions (DMRs) in the GNAS locus is observed in pseudohypoparathyroidism type 1B (PHP1B). Many PHP1B cases are sporadic, but autosomal dominant-PHP1B has a deletion involving NESP55 expressed from the maternal allele or STX16 located upstream of the GNAS locus on the maternal allele. We report the possible first familial PHP1B cases with retrotransposon insertion in the GNAS locus on the maternal allele.

View Article and Find Full Text PDF
Article Synopsis
  • Silver-Russel syndrome (SRS) is an imprinting disorder marked by growth failure and is diagnosed using the Netchine-Harbison clinical scoring system (NH-CSS) as the consensus clinical criteria.
  • A study of 173 patients meeting the NH-CSS found that 34.1% had loss of methylation of H19/IGF2 or maternal uniparental disomy chromosome 7, while 15% had pathogenic variants or copy number variants.
  • The research highlights the effectiveness of NH-CSS for diagnosis and reveals the genetic diversity within SRS, suggesting the need for more exploration of its "SRS spectrum."
View Article and Find Full Text PDF

Context: Children born small-for-gestational-age with short stature (SGA-SS) is associated with (epi)genetic defects, including imprinting disorders (IDs), pathogenic copy number variants (PCNVs), and pathogenic variants of genes involved in growth. However, comprehensive studies evaluating these 3 factors are very limited.

Objective: To clarify the contribution of PCNVs and candidate pathogenic variants to SGA-SS.

View Article and Find Full Text PDF
Article Synopsis
  • Infantile hemangioma (IH) is a common tumor in infants that usually resolves on its own, but many parents seek treatment for cosmetic reasons, with oral propranolol being the standard therapy, despite its potential side effects.* -
  • A study evaluated the use of a 5% propranolol cream on eight Japanese infants with IH, finding a 68.8% efficacy rate for treatment after 24 weeks, showing significant reductions in the tumor's surface area, diameter, and color intensity.* -
  • While adverse events were common (87.5%), none were directly related to the drug, suggesting that topical propranolol could be a safe and effective first-line treatment option for small and superficial IHs
View Article and Find Full Text PDF

Background And Objectives: Intravenous immunoglobulin (IVIG) therapy for acute-stage Kawasaki disease (KD) is the first-line treatment for preventing the development of coronary artery aneurysms (CAA). Corticosteroids (prednisolone) and infliximab are often used in patients at a high risk of CAA or those with CAA at diagnosis; however, there are only a few reports of non-responders to corticosteroids as an adjuvant therapy or rescue alternative to IVIG. In this study, we compared the therapeutic effects of primary and secondary prednisolone with IVIG for KD.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigates the role of imprinting disorders (IDs) in small-for-gestational-age with short stature (SGA-SS), focusing on Silver-Russell syndrome (SRS).
  • Researchers analyzed 249 patients after screening for genetic abnormalities, classifying them into three groups based on specific clinical criteria.
  • Findings revealed a significant presence of IDs among these patients, particularly with SRS-related genetic causes like methylation loss and uniparental disomy, indicating IDs are important factors in SGA-SS.
View Article and Find Full Text PDF
Article Synopsis
  • The study analyzed the major gene responsible for central precocious puberty in 24 Asian patients, focusing on Japanese and Chinese individuals.
  • Researchers examined DNA methylation and copy-number variations in 19 of these patients and found only one previously known mutation.
  • Results suggest that genetic defects in this condition are uncommon in Asian populations, likely due to specific mutations found in Western countries and a low occurrence of new mutations.
View Article and Find Full Text PDF

Context: Pseudohypoparathyroidism type I (PHP-I) is divided into PHP-Ia with Albright hereditary osteodystrophy and PHP-Ib, which usually shows no Albright hereditary osteodystrophy features. Although PHP-Ia and PHP-Ib are typically caused by genetic defects involving subunit of the stimulatory G protein (Gs)-coding exons and methylation defects of the differentially methylated regions (DMRs) on the maternal allele, respectively, detailed phenotypic characteristics still remains to be examined.

Objective: To clarify phenotypic characteristics according to underlying (epi)genetic causes.

View Article and Find Full Text PDF

Germline intragenic mutations in the GNAS locus result in pseudohypoparathyroidism type 1a (PHP1a) and related conditions. Nearly half of the previously reported GNAS intragenic mutations were structural variants, including 3 tandem duplications of 12-25 bp. However, the precise mutation spectrum and the genomic basis of GNAS structural variants remain to be clarified.

View Article and Find Full Text PDF

Background: Silver-Russell syndrome (SRS) is a rare congenital disorder characterized by pre- and postnatal growth failure and dysmorphic features. Recently, pathogenic copy number variations (PCNVs) and imprinting defects other than hypomethylation of the -differentially methylated region (DMR) and maternal uniparental disomy chromosome 7 have been reported in patients with the SRS phenotype. This study aimed to clarify the frequency and clinical features of patients with SRS phenotype caused by PCNVs.

View Article and Find Full Text PDF

Pseudohypoparathyroidism type 1b (PHP-1b) is usually diagnosed on various symptoms of hypocalcemia. Previous studies reported a few cases of autosomal dominant pattern PHP-1b identified on familial analysis with asymptomatic hypocalcemia. Herein we report the case of a 6-year-old male patient with sporadic PHP-1b incidentally detected on preoperative examination.

View Article and Find Full Text PDF

NR0B1 is the causative gene for X-linked adrenal hypoplasia congenita, characterized by adrenal insufficiency, hypogonadotropic hypogonadism, and infertility. We identified an NR0B1 frameshift mutation in a boy with precocious puberty who had no signs of adrenal insufficiency. Blood examination revealed elevated testosterone levels and gonadotropin hyperresponses to gonadotropin releasing hormone (GnRH) stimulation, together with normal adrenal hormone levels.

View Article and Find Full Text PDF

Purpose: Recent studies have identified multilocus imprinting disturbances (MLIDs) in a subset of patients with imprinting diseases (IDs) caused by epimutations. We examined MLIDs in patients with Temple syndrome (TS14) and Kagami-Ogata syndrome (KOS14).

Methods: We studied four TS14 patients (patients 1-4) and five KOS14 patients (patients 5-9) with epimutations.

View Article and Find Full Text PDF

Context: Pseudohypoparathyroidism type 1b (PHP-1b) results from methylation defects at the G protein stimulatory α subunit (GNAS) exon A/B-differentially methylated region (DMR). Although microduplications in the GNAS region were recently identified in two PHP-1b patients, genetic information on these patients remained fragmentary.

Case Description: A 20-year-old Japanese male and his mother presented with hypocalcemia and elevated blood levels of intact PTH.

View Article and Find Full Text PDF

Although recent studies have often revealed the presence of multilocus imprinting disturbance (MLID) at differentially methylated regions (DMRs) in patients with imprinting disorders (IDs), most patients exhibit clinical features of the original ID only. Here we report a Japanese female patient with Beckwith-Wiedemann syndrome and pseudohypoparathyroidism type Ib. Molecular studies revealed marked methylation defects (MDs) at the Kv-DMR and the GNAS-DMRs and variable MDs at four additional DMRs, in the absence of a mutation in ZFP57, NLRP2, NLRP7, KHDC3L and NLRP5.

View Article and Find Full Text PDF